Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
1 clinical trials · Condition
◉ Watch Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
| Record | Firm | Date |
|---|---|---|
| Biomarkers of Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients (NCT05181202) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-02-07 |
Track Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients automatically
Every clearance here is in the API, with alerts when new ones post.